Sandbox: malabsorption: Difference between revisions

Jump to navigation Jump to search
Line 7: Line 7:
{| class="wikitable" style="border: 0px; font-size: 100%; margin: 3px;" align="center"
{| class="wikitable" style="border: 0px; font-size: 100%; margin: 3px;" align="center"
! colspan="2" rowspan="5" |Categories
! colspan="2" rowspan="5" |Categories
! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Cause
! colspan="2" rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Cause
| colspan="9" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestation'''
| colspan="9" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestation'''
! colspan="9" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Lab findings'''
! colspan="9" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Lab findings'''
Line 43: Line 43:
|-
|-
! colspan="2" rowspan="11" |Gastrointestinal
! colspan="2" rowspan="11" |Gastrointestinal
! style="background:#DCDCDC;" align="center" |[[Crohns disease]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Crohns disease]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 78: Line 78:
* [[Colonoscopy]] with [[biopsy]]
* [[Colonoscopy]] with [[biopsy]]
|-
|-
! style="background:#DCDCDC;" align="center" |[[Ulcerative colitis]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Ulcerative colitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 119: Line 119:
* [[Colonoscopy]] with [[biopsy]]
* [[Colonoscopy]] with [[biopsy]]
|-
|-
! style="background:#DCDCDC;" align="center" |[[Celiac disease]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Celiac disease]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 157: Line 157:
* [[IgA]] tissue transglutaminase antibody
* [[IgA]] tissue transglutaminase antibody
|-
|-
! style="background:#DCDCDC;" align="center" |[[Cystic fibrosis]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Cystic fibrosis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 187: Line 187:
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L
* Elevated [[Sweat chloride test|sweat chloride]] ≥60 mmol/L
|-
|-
! style="background:#DCDCDC;" align="center" |[[Chronic pancreatitis]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Chronic pancreatitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 221: Line 221:
* [[Endoscopic retrograde cholangiopancreatography|ERCP]]
* [[Endoscopic retrograde cholangiopancreatography|ERCP]]
|-
|-
! style="background:#DCDCDC;" align="center" |[[Microscopic colitis]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Microscopic colitis]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 259: Line 259:
** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells
** [[Lymphocytic]] [[colitis]] is characterized by ≥20 intraepithelial [[lymphocytes]] (IEL) per 100 surface epithelial cells
|-
|-
!Infective colitis
! colspan="2" |[[Infective colitis]]
!
!
!
!
Line 282: Line 282:
!
!
|-
|-
!Ischemic colitis
! colspan="2" |[[Ischemic colitis]]
!
!
!
!
Line 305: Line 305:
!
!
|-
|-
!Mesenteric ischemia
! colspan="2" |[[Mesenteric ischemia]]
!
!
!
!
Line 328: Line 328:
!
!
|-
|-
! style="background:#DCDCDC;" align="center" |[[Lactose intolerance]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Lactose intolerance]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 362: Line 362:
* [[Lactase]] activity assay
* [[Lactase]] activity assay
|-
|-
! style="background:#DCDCDC;" align="center" |[[Irritable bowel syndrome]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Irritable bowel syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 389: Line 389:
* Diagnosis of exclusion
* Diagnosis of exclusion
|-
|-
! rowspan="28" |Infection
! rowspan="32" |Infection
! rowspan="15" |Bacterial
! rowspan="19" |Bacterial
! style="background:#DCDCDC;" align="center" |[[Whipple's disease]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Whipple's disease]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 430: Line 430:
* [[PCR]] testing
* [[PCR]] testing
|-
|-
! style="background:#DCDCDC;" align="center" |[[Tropical sprue]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Tropical sprue]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 463: Line 463:
* Diagnosis of exclusion
* Diagnosis of exclusion
|-
|-
! style="background:#DCDCDC;" align="center" |[[Small bowel bacterial overgrowth syndrome|Small bowel bacterial overgrowth]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Small bowel bacterial overgrowth syndrome|Small bowel bacterial overgrowth]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 500: Line 500:
* Diagnosis of exclusion
* Diagnosis of exclusion
|-
|-
!Food poisoning
! colspan="2" |[[Foodborne illness|Food poisoning]]
!
!
!
!
Line 523: Line 523:
!
!
|-
|-
!Pseudomembranous colitis
! colspan="2" |[[Pseudomembranous enterocolitis|Pseudomembranous colitis]]
!+
!+
!-
!-
Line 562: Line 562:
* CT
* CT
|-
|-
!Shigellosis
! colspan="2" |[[Shigella]]
!
!
!
!
Line 585: Line 585:
!
!
|-
|-
!Salmonella
! colspan="2" |[[Salmonella]]
!
!
!
!
Line 608: Line 608:
!
!
|-
|-
!Campylobacter jejuni
! colspan="2" |[[Campylobacter jejuni]]
!
!
!
!
Line 631: Line 631:
!
!
|-
|-
!E-coli
! rowspan="5" |[[Escherichia coli|E-coli]]
|[[ETEC]]
!
!
!
!
Line 654: Line 655:
!
!
|-
|-
!Yersinia enterocolitica
|[[EPEC]]
!
!
!
!
Line 677: Line 678:
!
!
|-
|-
!Vibrio cholera
|[[EIEC]]
!
!
!
!
Line 700: Line 701:
!
!
|-
|-
!Aeromonas
|[[EHEC]]
!
!
!
!
Line 723: Line 724:
!
!
|-
|-
!Plesiomonas
|[[EAEC]]
!
!
!
!
Line 746: Line 747:
!
!
|-
|-
![[Mycobacterium avium complex]]
! colspan="2" |Yersinia enterocolitica
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
! colspan="2" |Vibrio cholera
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
! colspan="2" |Aeromonas
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
! colspan="2" |Plesiomonas
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
!
|-
! colspan="2" |[[Mycobacterium avium complex]]
!
!
!+
!+
Line 772: Line 865:
!
!
|-
|-
!Other infections
! colspan="2" |Other infections
* aaaa
* aaaa
* bbbb
* bbbb
Line 802: Line 895:
|-
|-
! rowspan="8" |Virus
! rowspan="8" |Virus
!Rotavirus
! colspan="2" |Rotavirus
!
!
!
!
Line 825: Line 918:
!
!
|-
|-
!Echovirus
! colspan="2" |Echovirus
!
!
!
!
Line 848: Line 941:
!
!
|-
|-
!Adenovirus
! colspan="2" |Adenovirus
!
!
!
!
Line 871: Line 964:
!
!
|-
|-
!Norovirus
! colspan="2" |Norovirus
!
!
!
!
Line 894: Line 987:
!
!
|-
|-
!CMV colitis
! colspan="2" |CMV colitis
!
!
!+
!+
Line 920: Line 1,013:
!
!
|-
|-
!HIV
! colspan="2" |HIV
!
!
!
!
Line 943: Line 1,036:
!
!
|-
|-
! rowspan="2" |Hepatitis
!Hepatitis A
!Hepatitis A
!
!
Line 990: Line 1,084:
|-
|-
! rowspan="5" |Parasite
! rowspan="5" |Parasite
!Entamoeba histolytica
! colspan="2" |Entamoeba histolytica
!
!
!
!
Line 1,013: Line 1,107:
!
!
|-
|-
!Giardiasis
! colspan="2" |Giardiasis
!
!
!
!
Line 1,036: Line 1,130:
!
!
|-
|-
!Cryptosporidiosis
! colspan="2" |Cryptosporidiosis
!
!
!
!
Line 1,059: Line 1,153:
!
!
|-
|-
!Microsporidiosis
! colspan="2" |Microsporidiosis
!
!
!
!
Line 1,082: Line 1,176:
!
!
|-
|-
!Isosporiasis
! colspan="2" |Isosporiasis
!
!
!+
!+
Line 1,107: Line 1,201:
!
!
!
!
!Other Parasitic diarrhea
! colspan="2" |Other Parasitic diarrhea
* aaaa
* aaaa
* bbbb
* bbbb
Line 1,133: Line 1,227:
|-
|-
! colspan="2" rowspan="6" |Tumors
! colspan="2" rowspan="6" |Tumors
!Carcinoid tumor
! colspan="2" |Carcinoid tumor
!
!
!
!
Line 1,156: Line 1,250:
!
!
|-
|-
! style="background:#DCDCDC;" align="center" |[[VIPoma]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[VIPoma]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 1,196: Line 1,290:
* Followed by imaging
* Followed by imaging
|-
|-
! style="background:#DCDCDC;" align="center" |[[Zollinger-Ellison syndrome]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Zollinger-Ellison syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 1,225: Line 1,319:
* Elevated basal or stimulated serum [[gastrin]]> 120 pg/mL
* Elevated basal or stimulated serum [[gastrin]]> 120 pg/mL
|-
|-
!Somatostatinoma
! colspan="2" |Somatostatinoma
!
!
!
!
Line 1,248: Line 1,342:
!
!
|-
|-
!GI lymphoma
! colspan="2" |GI lymphoma
!
!
!
!
Line 1,271: Line 1,365:
!
!
|-
|-
!Colorectal cancer
! colspan="2" |Colorectal cancer
!
!
!+
!+
Line 1,298: Line 1,392:
|-
|-
! colspan="2" rowspan="5" |Medication/Toxicity
! colspan="2" rowspan="5" |Medication/Toxicity
!Drug induced enteritis
! colspan="2" |Drug induced enteritis
!
!
!
!
Line 1,321: Line 1,415:
!
!
|-
|-
!Chronic laxative abuse
! colspan="2" |Chronic laxative abuse
!
!
!
!
Line 1,344: Line 1,438:
!
!
|-
|-
!Heavy metal ingestion
! colspan="2" |Heavy metal ingestion
!
!
!
!
Line 1,367: Line 1,461:
!
!
|-
|-
!Organophosphate poisoning
! colspan="2" |Organophosphate poisoning
!
!
!
!
Line 1,390: Line 1,484:
!
!
|-
|-
!Opium withdrawal
! colspan="2" |Opium withdrawal
!
!
!
!
Line 1,414: Line 1,508:
|-
|-
! colspan="2" rowspan="3" |Iatrogenic
! colspan="2" rowspan="3" |Iatrogenic
! style="background:#DCDCDC;" align="center" |[[Short bowel syndrome]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Short bowel syndrome]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 1,452: Line 1,546:
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |  
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |  
|-
|-
!Radiation enteritis
! colspan="2" |Radiation enteritis
!
!
!
!
Line 1,475: Line 1,569:
!
!
|-
|-
!Dumping syndrome
! colspan="2" |Dumping syndrome
!
!
!
!
Line 1,499: Line 1,593:
|-
|-
! colspan="2" rowspan="4" |Others
! colspan="2" rowspan="4" |Others
! style="background:#DCDCDC;" align="center" |[[Abetalipoproteinemia]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Abetalipoproteinemia]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 1,533: Line 1,627:
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level
* Clinical findings and low [[triglyceride]] and [[cholesterol]] level
|-
|-
! style="background:#DCDCDC;" align="center" |[[Hyperthyroidism]]
! colspan="2" style="background:#DCDCDC;" align="center" |[[Hyperthyroidism]]
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | -
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | +
Line 1,570: Line 1,664:
* [[TSH]]
* [[TSH]]
|-
|-
!Diabetic neuropathy
! colspan="2" |Diabetic neuropathy
!
!
!
!
Line 1,593: Line 1,687:
!
!
|-
|-
!Diffuse systemic sclerosis
! colspan="2" |Diffuse systemic sclerosis
!
!
!
!

Revision as of 16:04, 12 December 2017

Diarrhea

Abbreviations: GI: Gastrointestinal; WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A

Categories Cause Clinical manifestation Lab findings Extra intestinal findings Cause/Pathogenesis Gold standard diagnosis
Symptoms GI signs
Duration Diarrhea Fever Abdominal pain Weight loss
Stool exam CBC Other lab findings
Acute Chronic Watery Bloody Fatty WBC RBC Ova/Parasite Osmotic gap Other WBC Hgb Plt
Gastrointestinal Crohns disease - + + + + ± + + + + - - -
  • Abnormal immune response to self antigens
Ulcerative colitis - + + + + + + + -
  • Hypoalbuminemia
  • Hypokalemia
  • Hypomagnesemia
  • Iron deficiency
  • Elevated ESR
  • Elevated CRP
  • Abnormal immune response to self antigens
Celiac disease - + ± - ± - + + - -
  • IgA endomysial antibody
  • Anti-tissue transglutaminase antibody
  • Anti-gliadin antibody
  • IgA endomysial antibody
  • IgA tissue transglutaminase antibody
Cystic fibrosis - + - - + ± + + - -
  • Positive DNA analysis for CFTR
  • Evaluated nasal transepithelial potential difference (NPD)
Chronic pancreatitis - + + - + - + + - - -
  • Slightly elevated amylase and lipase
  • Abnormal pancreatic function test
  • Repeated acute pancreatitis
  • Alcohol abuse
  • Genetic
  • Autoimmune
Microscopic colitis - + + + - - + + - - -
Infective colitis
Ischemic colitis
Mesenteric ischemia
Lactose intolerance + + + - - - + - - - -
Irritable bowel syndrome - + ± - ± - ± - - - - -
  • Diagnosis of exclusion
Infection Bacterial Whipple's disease - + + - + ± + + - - - ↓/↑
Tropical sprue + + + - + + + + - -
  • Diagnosis of exclusion
Small bowel bacterial overgrowth - + + - + - + + - -
  • Excess bacteria in the small intestine
  • Alterations in intestinal anatomy or GI motility, 
  • Lack of gastric acid secretion
  • Diagnosis of exclusion
Food poisoning
Pseudomembranous colitis + - + +/- - + + +/-
  • Abdominal tenderness
  • Presence of pseudomembranes of endoscopy
  • Enzyme immunoassay (EIA) for C difficile toxin A and B
  • Polymerase chain reaction (PCR) assay or C difficile antigen (glutamate dehydrogenase [GDH]) EIA
  • Leukocytosis
  • Elevated serum creatinine
  • Hypoalbuminemia
  • Anasarca
  • Elevated serum lactate
  • Recent antibiotics use
  • Recent surgery
  • Colon cancer
  • Diverticulitis
  • Appendicitis
  • Stool exam
  • CT
Shigella
Salmonella
Campylobacter jejuni
E-coli ETEC
EPEC
EIEC
EHEC
EAEC
Yersinia enterocolitica
Vibrio cholera
Aeromonas
Plesiomonas
Mycobacterium avium complex + + +/- + -
+/- + - -
- -
  • Immune system analysis may show defects
Other infections
  • aaaa
  • bbbb
+ + - + +/-
+ + - -
  • Stool culture may be positive for responsible organism
- -
Virus Rotavirus
Echovirus
Adenovirus
Norovirus
CMV colitis + + +/- + -
+/- + - -
- -
  • CD 4 level decreased as it is maily associated with HIV
HIV
Hepatitis Hepatitis A
Hepatitis E
Parasite Entamoeba histolytica
Giardiasis
Cryptosporidiosis
Microsporidiosis
Isosporiasis + + + - + + - - -
Other Parasitic diarrhea
  • aaaa
  • bbbb
+ + + - + +/- + + + - - -
Tumors Carcinoid tumor
VIPoma + + + - + - + + - - -
  • Primary secretory tumor
  • Elevated VIP levels
  • Followed by imaging
Zollinger-Ellison syndrome - + + - + - + + - -
  • Elevated basal or stimulated serum gastrin> 120 pg/mL
Somatostatinoma
GI lymphoma
Colorectal cancer + + + +
- + - -
- ↑/↓ -
  • May be associated with FAP gene or HNPCC gene
Medication/Toxicity Drug induced enteritis
Chronic laxative abuse
Heavy metal ingestion
Organophosphate poisoning
Opium withdrawal
Iatrogenic Short bowel syndrome + + + - + - - + -
  • Prior intestinal surgery
  • Surgical intestinal resection
Radiation enteritis
Dumping syndrome
Others Abetalipoproteinemia - + + - + - + + - - -
Hyperthyroidism - + + - - ± + + - - -
  • Elevated T4
  • Elevated T3
  • Decreased TSH
Diabetic neuropathy
Diffuse systemic sclerosis